Medication info
Dimetin Tablet (Memantine Hydrochloride)

Dimetin Tablet (Memantine Hydrochloride)

Prescription medicationTabletOral
Ingredient · strength
Memantine Hydrochloride›10mg / 1 tablet
Manufacturer / importer
Youngpoong Pharmaceutical Co., Ltd.
Appearance
White oval film-coated tablets
Packaging
30 tablets (10 tablets/PTP×3) - 30 tablets/PTP[(10 tablets/PTP×3)], 30 tablets/bottle - 30 tablets/PTP, 100 tablets/bottle - 100 tablets/bottle, 500 tablets/bottle - 500 tablets/bottle
Approval status
Active

MFDS item code 200502472 · Notified 2005.01.24 · Insurance code 661900170

Summary

Main use
Treatment of moderate to severe Alzheimer’s disease
Who takes it
Adults
Adult dose
Adults Dose titration: The maximum daily dose is 20mg. To minimize the risk of adverse reactions, increase the dose by 5mg per week over the first 3 weeks as follows until the maintenance dose is reached. Week 1 (Day 1~7): Administer 5mg per day for 7 days. Week 2 (Day 8~14): Administer 10mg per day (5mg twice daily) for 7 days. Week 3 (Day 15~21): Administer 15mg per day (10mg in the morning and 5mg in the evening) for 7 days. From Week 4 onward: Administer 20mg per day (10mg twice daily). Maintenance dose: The recommended maintenance dose is 20mg per day (10mg twice daily). Elderly patients: Based on clinical data, the recommended dose for elderly patients aged 65 years or older is 20mg per day (10mg twice daily). Patients with renal impairment: No dose adjustment is necessary in patients with mild renal impairment (creatinine clearance: 50-80 mL/min). In patients with moderate renal impairment (creatinine clearance 30-50 mL/min), reduce the daily dose to 10mg. If well tolerated, the dose may be increased to 20mg per day according to the standard dose-titration regimen after at least 7 days of treatment. In patients with severe renal impairment (creatinine clearance 5-30 mL/min), reduce the daily dose to 10mg. Patients with hepatic impairment: No dose adjustment is necessary in patients with mild or moderate hepatic impairment (Child-Pugh A, Child-Pugh B). Since data on the use of memantine in patients with severe hepatic impairment are unavailable, it is preferable not to administer this medicine.

Ingredients

Manufacturer
Youngpoong Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of moderate to severe Alzheimer’s disease

  • Alzheimer's disease
View approved original text

This medication is used for the treatment of moderate to severe Alzheimer's disease. It helps improve memory decline and cognitive dysfunction caused by Alzheimer's disease. It plays a role in maintaining the patient's ability to perform daily activities and slowing the progression of symptoms.

How to take

Adult dose

Adults Dose titration: The maximum daily dose is 20mg. To minimize the risk of adverse reactions, increase the dose by 5mg per week over the first 3 weeks as follows until the maintenance dose is reached. Week 1 (Day 1~7): Administer 5mg per day for 7 days. Week 2 (Day 8~14): Administer 10mg per day (5mg twice daily) for 7 days. Week 3 (Day 15~21): Administer 15mg per day (10mg in the morning and 5mg in the evening) for 7 days. From Week 4 onward: Administer 20mg per day (10mg twice daily). Maintenance dose: The recommended maintenance dose is 20mg per day (10mg twice daily). Elderly patients: Based on clinical data, the recommended dose for elderly patients aged 65 years or older is 20mg per day (10mg twice daily). Patients with renal impairment: No dose adjustment is necessary in patients with mild renal impairment (creatinine clearance: 50-80 mL/min). In patients with moderate renal impairment (creatinine clearance 30-50 mL/min), reduce the daily dose to 10mg. If well tolerated, the dose may be increased to 20mg per day according to the standard dose-titration regimen after at least 7 days of treatment. In patients with severe renal impairment (creatinine clearance 5-30 mL/min), reduce the daily dose to 10mg. Patients with hepatic impairment: No dose adjustment is necessary in patients with mild or moderate hepatic impairment (Child-Pugh A, Child-Pugh B). Since data on the use of memantine in patients with severe hepatic impairment are unavailable, it is preferable not to administer this medicine.

Precautions

This medication should not be used by patients who are allergic to its components. Patients with severe liver or kidney damage should not take this medication, especially those with very low kidney function. This medication contains lactose and should not be used by patients with lactose intolerance or certain genetic metabolic disorders. Patients with epilepsy or a history of seizures should use this medication cautiously, and individuals at high risk for seizures should also be monitored closely. Using this medication in combination with other drugs that have similar effects may increase the risk of side effects, so it is advisable not to combine them. Patients with changes in urine acidity or certain kidney diseases should be carefully monitored while taking this medication. There is insufficient data for the use of this medication in patients with heart disease or uncontrolled hypertension, so it should be administered with caution. This medication may cause side effects such as dizziness, headache, constipation, drowsiness, and increased blood pressure; if these symptoms are severe, consult a physician. Rarely, symptoms such as mental confusion, hallucinations, or psychotic symptoms may occur, so if these symptoms appear, inform the healthcare provider immediately. This medication may interact with other drugs, so if you are taking other medications, be sure to inform your healthcare provider. Women who are pregnant or may become pregnant should use this medication only when the benefits outweigh the risks, as it may affect the fetus. Breastfeeding women should consider discontinuing breastfeeding while taking this medication, as it may be excreted in breast milk. The safety and effectiveness of this medication in children and adolescents under 18 years of age have not been established, so it is advisable not to use it. In case of overdose, symptoms such as confusion, drowsiness, dizziness, and vomiting may occur, and immediate emergency treatment should be sought. This medication may affect the patient's reaction time, increasing the risk of accidents while driving or operating machinery, so caution is required. Store out of reach of children, and avoid transferring the medication to other containers, as this may cause accidents or degrade the quality.

Side effects

  • Dizziness
  • headache
  • constipation
  • drowsiness
  • hypertension
  • fungal infection
  • drug hypersensitivity reaction
  • confusion
  • hallucinations
  • psychotic reactions
Show 22 more
  • balance disorders
  • gait disturbances
  • seizures
  • heart failure
  • venous thromboembolism/thrombosis
  • shortness of breath
  • vomiting
  • pancreatitis
  • elevated liver function test levels
  • hepatitis
  • fatigue
  • anxiety
  • aggression
  • delirium
  • unconsciousness
  • restlessness
  • psychosis
  • visual disturbances
  • convulsions
  • somnolence
  • coma
  • diplopia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air and moisture, so it should be stored in a tightly closed container. It is important to maintain a storage temperature between 1 degree and 30 degrees Celsius.

Appearance and packaging

Appearance

White oval film-coated tablets

Package unit

30 tablets (10 tablets/PTP×3) - 30 tablets/PTP[(10 tablets/PTP×3)], 30 tablets/bottle - 30 tablets/PTP, 100 tablets/bottle - 100 tablets/bottle, 500 tablets/bottle - 500 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.